HEPXIA

Welcome to the Brand page for “HEPXIA”, which is offered here for Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of gene therapy preparations;instruments and apparatus for the administration of gene therapy namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products;.

Its status is currently believed to be active. Its class is unavailable. “HEPXIA” is believed to be currently owned by “Oxford BioMedica plc”.